Get started

Olav Thon Stiftelsen

Alternate names: The Olav Thon Foundation, Olav Thon Foundation
Description: Norwegian foundation
Country: NO
ROR: 014am8n90
Wikidata ID: wiki/Q15302794
Crossref ID: 501100021720
DOI: 10.13039/501100021720
OpenAlex ID: F4320331442
Hallmarks of neurodegenerative diseases
2023 · David M. Wilson, Mark R. Cookson, et al. · Cell · 1,914
PDF
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
2024 · Nicholas J. Ashton, Wagner S. Brum, et al. · JAMA Neurology · 988
PDF
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
2022 · Shorena Janelidze, Divya Bali, et al. · Brain · 543
PDF
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
2022 · Marta Milà-Alomà, Nicholas J. Ashton, et al. · Nature Medicine · 491
PDF
A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
2016 · Vincent Beliveau, Melanie Ganz, et al. · Journal of Neuroscience · 475
PDF
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
2022 · Nicholas J. Ashton, Shorena Janelidze, et al. · Nature Medicine · 467
PDF
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
2022 · Joseph Therriault, Tharick A. Pascoal, et al. · Nature Aging · 356
PDF
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
2023 · Bruna Bellaver, Guilherme Povala, et al. · Nature Medicine · 353
PDF
Molecular atlas of the adult mouse brain
2020 · Cantin Ortiz, Jose Fernandez Navarro, et al. · Science Advances · 293
PDF
Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
2022 · Fernando Gonzalez-Ortiz, Michael Turton, et al. · Brain · 280
PDF
Blood-based molecular biomarkers for Alzheimer’s disease
2019 · Henrik Zetterberg, Samantha C. Burnham · Molecular Brain · 261
PDF
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
2022 · Alexa Pichet Binette, Shorena Janelidze, et al. · Alzheimer s & Dementia · 233
PDF
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
2022 · Denis S. Smirnov, Nicholas J. Ashton, et al. · Acta Neuropathologica · 232
PDF
Astrocytic Ca2+ signaling is reduced during sleep and is involved in the regulation of slow wave sleep
2020 · Laura Bojarskaite, Daniel M. Bjørnstad, et al. · Nature Communications · 229
PDF
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
2023 · Gemma Salvadó, Rik Ossenkoppele, et al. · EMBO Molecular Medicine · 218
Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
2022 · Joshua Stevenson-Hoare, Amanda Heslegrave, et al. · Brain · 193
PDF
Metabolic alterations in Parkinson’s disease astrocytes
2020 · Tuuli-Maria Sonninen, Riikka H. Hämäläinen, et al. · Scientific Reports · 190
PDF
Sleep cycle-dependent vascular dynamics in male mice and the predicted effects on perivascular cerebrospinal fluid flow and solute transport
2023 · Laura Bojarskaite, Alexandra Vallet, et al. · Nature Communications · 168
PDF
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
2018 · Sara Hall, Shorena Janelidze, et al. · Scientific Reports · 162
PDF
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
2022 · João Pedro Ferrari-Souza, Pâmela C. L. Ferreira, et al. · Molecular Psychiatry · 153
PDF
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease
2025 · Hamilton Se-Hwee Oh, Deniz Yagmur Urey, et al. · Nature Medicine · 144
PDF
The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity
2022 · Dalia Ali, Michaela Tencerova, et al. · Frontiers in Endocrinology · 140
PDF
Blood-based biomarkers for Alzheimer’s disease—An update
2018 · Henrik Zetterberg · Journal of Neuroscience Methods · 136
PDF
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
2023 · Laia Montoliu-Gaya, Andréa L. Benedet, et al. · Nature Aging · 135
PDF
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
2025 · Joseph Therriault, Wagner S Brum, et al. · The Lancet Neurology · 131
Works count: 497
Citation count: 19,480
H-index: 61
I10-index: 326
2-year mean citedness: 20.4
Awards count: 54
Year
Topic
Type